The U.S. Food and Drug Administration (FDA) has authorized a new sunscreen ingredient for the first time in nearly 30 years. While other international regulatory bodies have approved various ultraviolet (UV) filters in recent decades, the U.S. market has operated under a more limited list of permitted active ingredients.
In the United States, sunscreen is regulated as an over-the-counter drug rather than a cosmetic, a classification that requires more extensive safety and efficacy testing. This regulatory framework has led to a slower approval process for new chemical filters compared to Europe and Asia, where such products are often categorized differently.
Public interest groups and skincare advocates have lobbied for administrative changes to speed up the innovation cycle for sun protection. A new proposal aims to streamline the FDA's review process for drug and sunscreen ingredients to bring U.S. standards closer to those utilized by other global health agencies.
The FDA maintains that its rigorous testing protocols are necessary to ensure the long-term safety of ingredients absorbed through the skin. Proponents of the new ingredients argue that updated UV filters offer better protection against skin cancer and are more aesthetically suitable for a wider range of skin tones.